IMMTAC Trademark

Trademark Overview

On Monday, December 12, 2016, a trademark application was filed for IMMTAC with the United States Patent and Trademark Office. The USPTO has given the IMMTAC trademark a serial number of 87265023. The federal status of this trademark filing is SECTION 8 - ACCEPTED as of Saturday, March 29, 2025. This trademark is owned by Immunocore Limited. The IMMTAC trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of cancer; biological preparations for the treatment of cancer; biological preparations for medical use for the treatment of cancer; immunotherapeutic drugs; reagents for medical use; diagnostic preparations for medical purposes; diagnostic reagents for medical use
immtac

General Information

Serial Number87265023
Word MarkIMMTAC
Filing DateMonday, December 12, 2016
Status701 - SECTION 8 - ACCEPTED
Status DateSaturday, March 29, 2025
Registration Number5410176
Registration DateTuesday, February 27, 2018
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 12, 2017

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of cancer; biological preparations for the treatment of cancer; biological preparations for medical use for the treatment of cancer; immunotherapeutic drugs; reagents for medical use; diagnostic preparations for medical purposes; diagnostic reagents for medical use

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, December 15, 2016
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameImmunocore Limited
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressAbingdon, Oxfordshire OX144RY
GB
Party NameImmunocore Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressAbingdon, Oxfordshire OX144RY
GB
Party NameImmunocore Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressAbingdon, Oxfordshire OX144RY
GB

Trademark Events

Event DateEvent Description
Thursday, December 15, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, December 15, 2016NEW APPLICATION ENTERED
Wednesday, March 22, 2017NON-FINAL ACTION E-MAILED
Wednesday, March 22, 2017NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, October 25, 2017NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, March 14, 2017ASSIGNED TO EXAMINER
Wednesday, March 22, 2017NON-FINAL ACTION WRITTEN
Tuesday, September 19, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, September 26, 2017ASSIGNED TO LIE
Saturday, September 30, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Saturday, September 30, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, October 25, 2017EXAMINERS AMENDMENT E-MAILED
Wednesday, October 25, 2017EXAMINERS AMENDMENT -WRITTEN
Wednesday, October 25, 2017EXAMINER'S AMENDMENT ENTERED
Tuesday, October 31, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, November 3, 2017ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Wednesday, November 8, 2017ELECTRONIC RECORD REVIEW COMPLETE
Wednesday, November 22, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, December 12, 2017PUBLISHED FOR OPPOSITION
Tuesday, December 12, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 27, 2018REGISTERED-PRINCIPAL REGISTER
Wednesday, December 28, 2022ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Wednesday, November 20, 2024ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Saturday, March 29, 2025CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Saturday, March 29, 2025REGISTERED - SEC. 8 (6-YR) ACCEPTED
Saturday, March 29, 2025NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
Monday, February 27, 2023COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Monday, August 26, 2024TEAS SECTION 8 RECEIVED

Related Keywords

immtac preparations medical treatment cancer diagnostic biological reagents purposes immunotherapeutic pharmaceutical